Icobrain MS, an AI tool for assessing MRI scans, being tested in UK

An upcoming study will investigate how well icobrain MS, an artificial intelligence (AI)-based technology, can interpret MRI data from people with multiple sclerosis (MS) and how its use might influence patient care. The project, called AssistMS and led by Icometrix -- the technology's developer -- and Queen Mary University of London (QMUL), is supported by an AI Award in Health and Care from the U.K.'s National Institute for Care and Health Research (NIHR). Called "Artificial intelligence-assisted magnetic resonance imaging for quality, efficiency and equity in the NHS care of multiple sclerosis (AssistMS)," the project ultimately aims to improve MS care, according to Icometrix. "If successful, AssistMS will have a significant impact on [MS patient's] quality of life as well as equity and efficiency of MS care across the UK," Klaus Schmierer, PhD, a professor of neurology at QMUL and a study lead investigator, said in an Icometrix press release. MS patients routinely undergo MRI scans of the brain and spinal cord to monitor disease activity and response to disease-modifying treatments.